Response to letter to the editor: ‘Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis’
Restricted accessLetterFirst published online July, 2025
Response to letter to the editor: ‘Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis’
ChristensenRJollyAYamC, et al. Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis. Mult Scler2025; 31(2): 218–230.
2.
Cerdá-FuertesNStoesselMMickeliunasG, et al. Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis. Mult Scler2023; 29(13): 1540–1550.
3.
GranzieraCWuerfelJBarkhofF, et al. Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis. Brain2021; 144(5): 1296–1311.
